Redbiotec is privately owned and backed by pharma-experienced institutional and private investors.
To find out more about investment opportunities with Redbiotec, please contact us.
Our current investors are:
|Redalpine Capital I||Swiss venture fund.|
|V+ GmbH & Co Fonds 2 KG||German venture capital fund.|
|Zürcher Kantonalbank (ZKB Group)||Switzerland’s largest cantonal bank. S&P: AAA Rating.|
Backed by experienced private investors.